Cargando…

Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis

INTRODUCTION: Interstitial lung disease (ILD) is a common manifestation of scleroderma/systemic sclerosis (SSc). However, the direct and indirect economic burdens of SSc-ILD remain unclear. This study assessed and compared healthcare resource utilization (HRU), direct healthcare costs, work loss, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zhou, Fan, Yanni, Thomason, Darren, Tang, Wenxi, Liu, Xinyue, Zhou, Zheng-Yi, Macaulay, Dendy, Fischer, Aryeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824377/ https://www.ncbi.nlm.nih.gov/pubmed/30929184 http://dx.doi.org/10.1007/s12325-019-00929-2

Ejemplares similares

Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims Data
por: Yamazaki, Kiyotaka, et al.
Publicado: (2019)

Economic burden of interstitial lung disease in a commercially insured population with Sjögren syndrome in the United States
por: Lee, Tsung-Ying, et al.
Publicado: (2022)

Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis
por: Strand, Vibeke, et al.
Publicado: (2018)

Economic burden related to fistulas or strictures among commercially insured patients with Crohn’s disease in the United States
por: Fan, Yanni, et al.
Publicado: (2023)

Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States
por: Lu, Mei, et al.
Publicado: (2021)

Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)

Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data
por: Huang, Yunyu, et al.
Publicado: (2016)

The Economic Burden of Stroke Based on South Korea’s National Health Insurance Claims Database
por: Cha, Yu-Jin
Publicado: (2018)

Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
por: Mostaghimi, Arash, et al.
Publicado: (2022)

Disease Burden of Spinal Muscular Atrophy: A Comparative Cohort Study Using Insurance Claims Data in the USA
por: Mouchet, Julie, et al.
Publicado: (2023)

Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA
por: Olson, Amy L., et al.
Publicado: (2020)

The Economic Value of Improved Productivity from Treatment of Chronic Hepatitis C Virus Infection: A Retrospective Analysis of Earnings, Work Loss, and Health Insurance Data
por: Sulkowski, Mark, et al.
Publicado: (2020)

The prevalence and burden of interstitial lung diseases in the USA
por: Jeganathan, Niranjan, et al.
Publicado: (2021)

Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: Analysis of claims-based databases, 2006–2010
por: Krishnarajah, Girishanthy, et al.
Publicado: (2014)

The long‐term direct and indirect economic burden among Parkinson's disease caregivers in the United States
por: Martinez‐Martin, Pablo, et al.
Publicado: (2018)

The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
por: Sacks, Naomi C., et al.
Publicado: (2022)

2145. Economic Burden of Congenital Cytomegalovirus Infection in Commercially- and Medicaid-insured Patients in the United States
por: Diaz-Decaro, John D, et al.
Publicado: (2022)

Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis
por: Placzek, Hilary, et al.
Publicado: (2015)

Health economic burden of patients with phenylketonuria (PKU) – A retrospective study of German health insurance claims data
por: Trefz, Friedrich, et al.
Publicado: (2021)

Surgical specialty and preoperative medical consultation based on commercial health insurance claims
por: Thilen, Stephan R., et al.
Publicado: (2018)

Claims-based proxies of patient instability among commercially insured adults with schizophrenia
por: Ruetsch, Charles, et al.
Publicado: (2018)

Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data
por: Tranby, Eric P., et al.
Publicado: (2022)

Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims
por: BUCK, P. O., et al.
Publicado: (2017)

Economic Burden of Anemia in an Insured Population
por: Nissenson, Allen R., et al.
Publicado: (2005)

Economic burden of acute steroid-refractory graft-versus-host disease in commercially insured pediatric patients
por: Grabner, Michael, et al.
Publicado: (2021)

Economic Burden of Metastatic Ovarian Cancer in a Commercially Insured Population: A Retrospective Cohort Analysis
por: Chin, Lauren, et al.
Publicado: (2020)

Economic Burden of Comorbidities in Patients with Psoriasis in the USA
por: Wu, Jashin J., et al.
Publicado: (2022)

Research on the Effect of Commercial Health Insurance Development on Economic Efficiency
por: Zhao, Tongpu, et al.
Publicado: (2023)

Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention
por: Fischer, Aryeh, et al.
Publicado: (2019)

Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database
por: Broder, Michael S., et al.
Publicado: (2018)

Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database
por: Hu, Eric, et al.
Publicado: (2023)

Clinical and economic burden of prescribing tramadol and other opioids for patients with osteoarthritis in a commercially insured population in the United States
por: Silverman, Stuart, et al.
Publicado: (2022)

Economic burden of spinal muscular atrophy: an analysis of claims data
por: Belter, Lisa, et al.
Publicado: (2020)

Updated cost-of-care estimates for commercially insured patients with multiple sclerosis: retrospective observational analysis of medical and pharmacy claims data
por: Carroll, Cathryn A, et al.
Publicado: (2014)

Interstitial lung disease in suggestive forms of connective tissue disease
por: Fischer, Aryeh
Publicado: (2013)

Hospital Claims and the Insurance Surplus
Publicado: (1921)

Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
por: Smoyer-Tomic, Karen E, et al.
Publicado: (2012)

Economic Burden of Irritable Bowel Syndrome with Constipation: A Retrospective Analysis of Health Care Costs in a Commercially Insured Population
por: Doshi, Jalpa A., et al.
Publicado: (2014)

Economic burden of paediatric-onset disabilities among young and middle-aged adults in the USA: a cohort study of privately insured beneficiaries
por: Whitney, Daniel, et al.
Publicado: (2019)

The clinical and economic burden of chronic obstructive pulmonary disease in the USA
por: Guarascio, Anthony J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_59nuik0k3287o06v7qngp88opd